Three Areas Payers Are Redefining Following COVID-19
Intouch SVP of market access Mike Motto weighs in on how, in addition to value and technology, new payer partnerships and acquisitions are influencing this evolution.
112 Search Results
Intouch SVP of market access Mike Motto weighs in on how, in addition to value and technology, new payer partnerships and acquisitions are influencing this evolution.
In the face of relentless trauma, how can pharma more effectively convey important information while also building, improving, and sustaining relationships with HCPs as they care for patients? An Intouch MD weighs in.
The Now & The Next in Pharma Marketing Offers Real-World Solutions Brands Can Start Implementing Today NEW YORK, NY (January 5, 2021) — The DHC Group and Intouch Group announced that, together, they have published a new whitepaper titled The Now & The Next in Pharma Marketing. The whitepaper delves deep into practical solutions for the challenges pharmaceutical commercial organizations continue to face as a result of the COVID-19 pandemic. Areas covered include evolving the pharmaceutical marketing commercial strategy, real-world solutions and specific tactics […]
Many brand teams follow the same planning process year after year, but during the pandemic, the parameters have shifted dramatically. How can marketers plan for the future when there are so many unknowns? Read on to find out.
In early March 2020, the violator - a simple badge, or on-page announcement - began to appear on websites. COVID-19 violators are now ubiquitous. Find out why this should matter to pharma marketers.
COVID-19 has been a wake-up call for pharma to evaluate their organization’s digital maturity and ability to serve customers personalized experiences. Is your organization ready?
Intouch’s Inclusion and Diversity Alliance recently hosted a cross-office Zoom panel on how employees are being emotionally and psychologically affected by COVID-19. Read on to learn their stories.
The healthcare industry is still coping with the changes the pandemic has forced upon it -- and many of these changes likely won’t be reversed. Where does pharma fit now and in 2021? Get the Intouch/DHC Group whitepaper to find out.
The DHC Group and Intouch Group announced that, together, they published a whitepaper titled, “The Aftermath: COVID-19 Insights and Recommendations - How the Pandemic Will Forever Change Pharma Sales and Marketing.”
DTC Perspectives recently hosted a webinar – Virtual DTC National: A COVID-19 Focused Event – that addressed how the COVID-19 pandemic has so far affected patients and other pharmaceutical and healthcare stakeholders. Get key takeaways from the event and register for Intouch's new whitepaper on the aftermath of COVID-19.
Page 1 of 12